These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24581519)

  • 1. Efficacy and safety of ultrasound-guided transrectal ethanol injection for the treatment of benign prostatic hyperplasia in patients with high-risk comorbidities: a long-term study at a single tertiary care institution.
    Li Y; Zhao Q; Dong L
    Urology; 2014 Mar; 83(3):586-91. PubMed ID: 24581519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up.
    Sakr M; Eid A; Shoukry M; Fayed A
    Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of transurethral ethanol ablation of prostate for symptomatic benign prostatic hyperplasia.
    Faruque MS; Alam MK; Ullah MA; Rahman MH; Kibria MG; Haque MM; Haque MA; Joarder AI; Paul BK
    Mymensingh Med J; 2012 Apr; 21(2):265-9. PubMed ID: 22561769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transurethral ethanol ablation of the prostate for symptomatic benign prostatic hyperplasia: long-term follow-up.
    El-Husseiny T; Buchholz N
    J Endourol; 2011 Mar; 25(3):477-80. PubMed ID: 21355774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous ethanol injection of the prostate as minimally invasive treatment for benign prostatic hyperplasia: preliminary report.
    Savoca G; De Stefani S; Gattuccio I; Paolinelli D; Stacul F; Belgrano E
    Eur Urol; 2001 Nov; 40(5):504-8. PubMed ID: 11752856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia.
    Chuang YC; Chiang PH; Yoshimura N; De Miguel F; Chancellor MB
    BJU Int; 2006 Nov; 98(5):1033-7; discussion 1337. PubMed ID: 16956361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral ethanol ablation of the prostate (TEAP): an effective minimally invasive treatment alternative to traditional surgery for symptomatic benign prostatic hyperplasia (BPH) in high-risk comorbidity patients.
    Magno C; Mucciardi G; Galì A; Anastasi G; Inferrera A; Morgia G
    Int Urol Nephrol; 2008; 40(4):941-6. PubMed ID: 18478352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.
    Bachmann A; Tubaro A; Barber N; d'Ancona F; Muir G; Witzsch U; Grimm MO; Benejam J; Stolzenburg JU; Riddick A; Pahernik S; Roelink H; Ameye F; Saussine C; Bruyère F; Loidl W; Larner T; Gogoi NK; Hindley R; Muschter R; Thorpe A; Shrotri N; Graham S; Hamann M; Miller K; Schostak M; Capitán C; Knispel H; Thomas JA
    Eur Urol; 2014 May; 65(5):931-42. PubMed ID: 24331152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
    Xu J; Qian WQ; Song JD
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BiVap saline vaporization of the prostate in men with benign prostatic hyperplasia: our clinical experience.
    Karakose A; Aydogdu O; Atesci YZ
    Urology; 2014 Mar; 83(3):570-5. PubMed ID: 24275275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three year results of the prostatic urethral L.I.F.T. study.
    Roehrborn CG; Rukstalis DB; Barkin J; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Cantwell AL; McVary KT; Te AE; Gholami SS; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rashid P
    Can J Urol; 2015 Jun; 22(3):7772-82. PubMed ID: 26068624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years.
    Chen S; Zhu L; Cai J; Zheng Z; Ge R; Wu M; Deng Z; Zhou H; Yang S; Wu W; Liao L; Tan J
    Eur Urol; 2014 Aug; 66(2):284-91. PubMed ID: 24502959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.
    Safarinejad MR
    J Herb Pharmacother; 2005; 5(4):1-11. PubMed ID: 16635963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
    J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective review of office-based 532-nm GreenLight laser prostatectomy in men with symptomatic benign prostatic hyperplasia.
    Osterberg EC; No D; Otto BJ; Naftali I; Choi BB
    Urology; 2013 Sep; 82(3):680-4. PubMed ID: 23987164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.